Harvest Partners LP, an investment firm based in the United States, has announced a growth investment alongside management and existing investor A&M Capital in Med-Metrix LLC, also based in the U.S., to support its expansion within the revenue cycle management (RCM) sector. The precise terms of the deal have not been disclosed.
| Acquirer | Harvest Partners LP, US |
|---|---|
| Target | Med-Metrix LLC, US |
| Deal Value | Undisclosed |
| Type | Growth Investment |
| Closing Date | 2025-06-24 |
| Announcement Date | 2025-06-24 |
| Buy-Side Advisors | Harvest Partners, Baird |
| Sell-Side Advisors | TripleTree, VRA Partners |
| Legal Buy-side | Kirkland & Ellis |
| Legal Sell-side | McDermott Will & Emery |
The investment aims to accelerate Med-Metrix's growth trajectory, leveraging Harvest Partners’ expertise in scaling healthcare businesses. The firm has a history of supporting companies within the RCM sector and sees significant potential for Med-Metrix.
Med-Metrix is a leading provider of RCM services, assisting healthcare organizations in optimizing their revenue cycles through technology and operational efficiency improvements. With this new capital injection, Med-Metrix plans to expand its service offerings and enhance technological capabilities to better serve the needs of its clients.
Deal Mechanics
The deal was facilitated by Harvest Partners alongside management and existing investor A&M Capital. Baird provided financial advice to Harvest Partners during the transaction, while TripleTree and VRA Partners acted as sell-side advisors for Med-Metrix.
Strategic Rationale
The investment is expected to bolster Med-Metrix’s position in the highly competitive RCM market by enabling it to invest more heavily in technology development, expand its geographic reach, and deepen service offerings. Harvest Partners’ involvement brings strategic insight into scaling businesses within healthcare, complementing Med-Metrix’s operational expertise.
Financial Context
The revenue cycle management industry continues to experience strong growth driven by increasing complexity in healthcare reimbursement regulations and the demand for more efficient financial operations in health systems. The investment from Harvest Partners will enable Med-Metrix to tap into this expanding market, positioning itself for future success.
Advisors
Legal counsel was provided to the buy-side by Kirkland & Ellis and to the sell-side by McDermott Will & Emery. Financial advice on the transaction came from Baird (buy-side) and TripleTree, VRA Partners (sell-side).
Outlook
This growth investment represents a strategic move for Med-Metrix to capitalize on the growing demand for RCM solutions in an increasingly complex healthcare landscape. With support from Harvest Partners, the company is well-positioned to achieve its ambitious goals and further establish itself as a leader in this sector.